Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Apollo Endosurgery Inc (NQ: APEN)
7.150 USD  +0.100 (+1.42%)
Official Closing Price  /  Updated: 4:00 PM EDT, Sep 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 65,800
Open 7.020
Bid (Size) 6.900 (4)
Ask (Size) 13.91 (6)
Prev. Close 7.050
Today's Range 6.900 - 7.255
52wk Range 3.750 - 9.649
Shares Outstanding 17,509,449
Dividend Yield N/A
Performance
YTD
+21.39%
+21.39%
1 Month
-4.28%
-4.28%
3 Month
+8.17%
+8.17%
6 Month
+12.78%
+12.78%
1 Year
+57.14%
+57.14%
Top News
More News
Analysis: Positioning to Benefit within Quanex Building Products, Molecular Templates, Atara Biotherapeutics, Forward Industries, Apollo Endosurgery, and Myomo — Research Highlights Growth, Revenue, a
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Quanex Building Products... Read More
from GlobeNewswire News Releases
Apollo Endosurgery, Inc. Reports Second Quarter 2018 Results
Apollo Endosurgery Reports First Quarter 2018 Results Read More
from Business Wire News Releases
More News
Read More
Apollo Endosurgery, Inc. to Report Second Quarter Results on August 8, 2018
from Business Wire News Releases
Apollo Endosurgery Receives Special 510(k) Clearance for OverStitch™ Sx Endoscopic Suturing System
from Business Wire News Releases
Apollo Endosurgery, Inc. Announces Closing of Public Offering of Common Stock and Underwriter’s Full Exercise of Over-Allotment Option
from Business Wire News Releases
Apollo Endosurgery, Inc. Announces Pricing of $20.6 Million Public Offering of Common Stock
from Business Wire News Releases
Apollo Endosurgery, Inc. Announces Commencement of Public Offering of Common Stock
from Business Wire News Releases
Apollo Endosurgery Announces Presentation of Mayo Clinic’s Clinical Study of ORBERA® Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis (NASH) at Digestive Disease Week® 2018 (DDW)
from Business Wire News Releases
Apollo Endosurgery Announces Presentation of Mortality and Inpatient Costs of Revisional Bariatric Surgery
from Business Wire News Releases
Apollo Endosurgery Announces FDA Approval of Revised Labeling for the ORBERA® Intragastric Balloon System
from Business Wire News Releases
Apollo Endosurgery Announces Presentation of Intragastric Balloon Comparison Study at Digestive Disease Week® 2018 titled: “Fluid-Filled Intragastric Balloons are Superior to Gas-Filled Balloon”
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.